7 Stocks Under $10 Making Big Moves
Array BioPharma
Array BioPharma (ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. This stock is trading up 5.4% at $3.68 in recent trading.
Today's Range: $3.49-$3.80
52-Week Range: $1.58-$3.53 Volume: 1.13 million Three-Month Average Volume: 868,835 Shares of ARRY are ripping higher today after the company announced encouraging selumetinib results for phase II trials in ovarian cancer. Selumetinib was invented by Array and licensed to AstraZeneca. From a technical perspective, ARRY is continuing a breakout pattern today now that the stock is comfortably above its recent breakout levels of $3.27 to $3.33. Volume so far is tracking in very strong and well above its average action of 868,835 shares. Traders should now watch for ARRY to close above its next major overhead resistance level of $3.60. If we get that close today, then look for ARRY to uptrend toward $4 to $4.25 or possibly higher in the near future. Traders should consider long biased traders as long as ARRY is trending above $3.60 with strong upside volume flows. Array shows up on a list of 7 Cancer Drug Stocks to Know Right Now.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
